Treatment Initially, 27 patients were treated with propranolol alone until control of hypertension was achieved, or side effects prevented a further increase in dosage, or a maximum dosage of 960 mg daily had been reached, whereupon polythiazide i mg daily was added; potassium supplements were not prescribed. Propranolol was always started cautiously in a low dosage of 40 mg daily and then increased weekly if possible by increments of 8o mg daily until the maximum daily dosage of 960 mg had been reached. At low dose ranges I0 mg and 40 mg tablets were used, but for higher dose ranges 8o mg tablets were prescribed.
Propranolol alone achieved good blood pressure control in 22 per cent of patients and, after the addition ofpolythiazide, the combination was successful in 43 per cent ofpatients. It is concluded that propranolol alone is only effective in a small proportion ofpatients with severe hypertension, but that in combination with a diuretic it may be an effective hypotensive agent.
Several workers have claimed that propranolol is an effective hypotensive drug (Prichard and Gillam, I969; Zacharias and Cowen, I970; Axford and Gilchrist, 197I) . Though diuretics have been used in combination with propranolol in a number of trials (Richardson et Treatment Initially, 27 patients were treated with propranolol alone until control of hypertension was achieved, or side effects prevented a further increase in dosage, or a maximum dosage of 960 mg daily had been reached, whereupon polythiazide i mg daily was added; potassium supplements were not prescribed. Propranolol was always started cautiously in a low dosage of 40 mg daily and then increased weekly if possible by increments of 8o mg daily until the maximum daily dosage of 960 mg had been reached. At low dose ranges I0 mg and 40 mg tablets were used, but for higher dose ranges 8o mg tablets were prescribed.
Criteria for control Blood pressure control was assessed as follows.
Good -diastolic blood pressure of ioo mmHg or less, without serious side effects. Fair -diastolic blood pressure greater than ioo mmHg but with a fall in diastolic pressure greater than io per cent without serious side effects. Poor -diastolic blood pressure greater than ioo mmHg, without a sustained fall in diastolic pressure
Only patients with 'good' control were considered as 'successes' in the final analysis. Those with 'fair' or 'poor' control or those who had to be withdrawn because of side effects were classified as 'failures'. To assess control, the mean lying and standing diastolic pressures obtained on three consecutive visits have been employed. All patients were left on the maximum dosage of propranolol for 4 weeks before failure was accepted and an alternative hypotensive agent used. P values were obtained by applying the paired group.bmj.com on April 9, 2017 -Published by http://heart.bmj.com/ Downloaded from (Zacharias, 197I) and 84 per cent (Prichard and Gilam, I969) .
Another factor that might possibly account for our results is that I0 patients (37%) were West Indian. Humphreys and Delvin (I968) showed that there was no significant difference between the effect of propranolol and a placebo in I8 Jamaican patients. There was no significant difference in the severity of hypertension, nor in the degree of control achieved between the West Indian and European patients in this study, and this suggests that a racial difference was not responsible for our results. The most likely explanation for our comparatively poor results is the severity of hypertension in our patients. The mean pretreatment blood pressure was 205/I24 mmHg, a level that appears to be higher than in most previous series.
The incidence of side effects was high. It is noteworthy that of the three patients withdrawn because of bronchospasm, none gave a previous history of chest symptoms. Tiredness and somnolence were troublesome in a number of patients, and in one patient it was necessary to stop therapy. Impotence is not considered to be a side effect of propranolol, though Zacharias (I97I) cautions that it may be commoner than suspected. Two male patients developed impotence and one woman demanded a change of therapy as she was unable to achieve any satisfaction from coitus; after cessation of therapy, her sexual responses were normal. Withdrawal symptoms occurred in 3 patients after the sudden cessation of propranolol, the clinical picture being similar to that of thyrotoxicosis, with tachycardia, anxiety, tremulousness, perspiration, and general malaise. These symptoms were abolished with as little as one-quarter of the original dose.
The average blood pressure after treatment with propranolol alone was I95/11I mmHg and after the addition of polythiazide was I65/I00 mmHg; the 'success' rate was increased from 22 per cent to 43 per cent (Table 2) 
